Avaliação de massa hipofisária

Referências

Principais artigos

Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317:516-524. Resumo

Molitch ME. Pathologic hyperprolactinemia. Endocrinol Metab Clin North Am. 1992;21:877-901. Resumo

Vance ML. Endocrinological evaluation of acromegaly. J Neurosurg. 1998;89:499-500. Resumo

Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93:1553-1562.Texto completo  Resumo

Artigos de referência

1. Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer. 2001 Dec;8(4):287-305.Texto completo  Resumo

2. Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317:516-524. Resumo

3. Pal A, Leaver L, Wass J. Pituitary adenomas. BMJ. 2019 Jun 6;365:l2091.Texto completo  Resumo

4. Nishioka H, Inoshita N. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol. 2018 Jan 9;35(2):57-61. Resumo

5. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004 Aug 1;101(3):613-9.Texto completo  Resumo

6. Morris Z, Whiteley WN, Longstreth WT Jr, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.Texto completo  Resumo

7. Colao A, Loche S, Cappa M, et al. Prolactinomas in children and adolescents: clinical presentation and long-term follow-up. J Clin Endocrinol Metab. 1998;83:2777-2780.Texto completo  Resumo

8. Randall RV, Scheithauer BW, Laws ER Jr, et al. Pituitary adenomas associated with hyperprolactinemia: a clinical and immunohistochemical study of 97 patients operated on transsphenoidally. Mayo Clin Proc. 1985;60:753-762. Resumo

9. Jagannathan J, Dumont AS, Jane JA Jr, et al. Pediatric sellar tumors: diagnostic procedures and management. Neurosurg Focus. 2005;18:E6. Resumo

10. Nieman LK. Medical therapy of Cushing's disease. Pituitary. 2002;5:77-82. Resumo

11. Klibanski A. Nonsecreting pituitary tumors. Endocrinol Metab Clin North Am. 1987;16:793-804. Resumo

12. Yamada S, Asa SL, Kovacs K, et al. Analysis of hormone secretion by clinically nonfunctioning human pituitary adenomas using the reverse hemolytic plaque assay. J Clin Endocrinol Metab. 1989;68:73-80. Resumo

13. Socin HV, Chanson P, Delemer B, et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol. 2003;148:433-442. Resumo

14. Beck-Peccoz P, Brucker-Davis F, Persani L, et al. Thyrotropin-secreting pituitary tumors. Endocr Rev. 1996;17:610-638. Resumo

15. Schubiger O, Haller D. Metastases to the pituitary-hypothalamic axis: an MR study of 7 symptomatic patients. Neuroradiology. 1992;34:131-134. Resumo

16. Heaney AP. Clinical review: Pituitary carcinoma: difficult diagnosis and treatment. J Clin Endocrinol Metab. 2011;96:3649-3660. Resumo

17. Joshi MN, Whitelaw BC, Carroll PV. MECHANISMS IN ENDOCRINOLOGY: Hypophysitis: diagnosis and treatment. Eur J Endocrinol. 2018 Jun 7;179(3):R151-R163.Texto completo  Resumo

18. Faje AT, Sullivan R, Lawrence D, et al. Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab. 2014 Nov;99(11):4078-85.Texto completo  Resumo

19. Min L, Hodi FS, Giobbie-Hurder A, et al. Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res. 2015 Feb 15;21(4):749-55.Texto completo  Resumo

20. Torino F, Barnabei A, Paragliola RM, et al. Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur J Endocrinol. 2013 Dec;169(6):R153-64.Texto completo  Resumo

21. Jadhav RN, Dahiwadkar HV, Palande DA. Abscess formation in invasive pituitary adenoma: case report. Neurosurgery. 1998;43:616-619. Resumo

22. Dalan R, Leow MK. Pituitary abscess: our experience with a case and a review of the literature. Pituitary. 2008;11:299-306. Resumo

23. Goyal P, Utz M, Gupta N, et al. Clinical and imaging features of pituitary apoplexy and role of imaging in differentiation of clinical mimics. Quant Imaging Med Surg. 2018 Mar;8(2):219-231.Texto completo  Resumo

24. Abbott J, Kirkby GR. Acute visual loss and pituitary apoplexy after surgery. BMJ. 2004;329:218-219.Texto completo  Resumo

25. Mohr G, Hardy J. Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol. 1982;18:181-189. Resumo

26. Levy A. Hazards of dynamic testing of pituitary function. Clin Endocrinol (Oxf). 2003;58:543-544. Resumo

27. Ucciferro P, Anastasopoulou C. Empty Sella. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019Texto completo  Resumo

28. Goyal P, Utz M, Gupta N, et al. Clinical and imaging features of pituitary apoplexy and role of imaging in differentiation of clinical mimics. Quant Imaging Med Surg. 2018 Mar;8(2):219-231.Texto completo  Resumo

29. Fernández-Balsells MM, Murad MH, Barwise A, et al. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2011 Apr;96(4):905-12.Texto completo  Resumo

30. Baldeweg SE, Vanderpump M, Drake W, et al. Society for Endocrinology endocrine emergency guidance: emergency management of pituitary apoplexy in adult patients. Endocr Connect. 2016 Sep;5(5):G12-G15.Texto completo  Resumo

31. Freda PU, Beckers AM, Katznelson L, et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:894-904.Texto completo  Resumo

32. Molitch ME. Pathologic hyperprolactinemia. Endocrinol Metab Clin North Am. 1992;21:877-901. Resumo

33. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744.Texto completo  Resumo

34. Fukuda I, Hizuka N, Murakami Y, et al. Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University. Intern Med. 2001;40:987-992.Texto completo  Resumo

35. Vance ML. Endocrinological evaluation of acromegaly. J Neurosurg. 1998;89:499-500. Resumo

36. Katznelson L, Laws ER Jr, Melmed S, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014 Oct 30;99(11):3933-51.Texto completo  Resumo

37. Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003 Dec;88(12):5593-602.Texto completo  Resumo

38. Lindholm J. Cushing's syndrome: historical aspects. Pituitary. 2000;3:97-104. Resumo

39. Cappabianca P, Cirillo S, Alfieri A, et al. Pituitary macroadenoma and diaphragma sellae meningioma: differential diagnosis on MRI. Neuroradiology. 1999;41:22-26. Resumo

40. Pinzer T, Krishnan KG, Schackert G. The diaphragma sellae meningioma: a rare differential diagnosis of non-functioning pituitary adenoma. Zentralbl Neurochir. 2004;65:195-197. Resumo

41. Scott ES, Long GV, Guminski A, et al. The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma. Eur J Endocrinol. 2018 Feb;178(2):173-180.Texto completo  Resumo

42. Ryder M, Callahan M, Postow MA, et al. Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution. Endocr Relat Cancer. 2014 Apr;21(2):371-81.Texto completo  Resumo

43. Famini P, Maya MM, Melmed S. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab. 2011;96:1633-1641. Resumo

44. Chin BM, Orlandi RR, Wiggins RH 3rd. Evaluation of the sellar and parasellar regions. Magn Reson Imaging Clin N Am. 2012;20:515-543. Resumo

45. American College of Radiology. ACR Appropriateness Criteria. Neuroendocrine Imaging. 2018 [internet publication].Texto completo

46. Shrivastava RK, Arginteanu MS, King WA, et al. Giant prolactinomas: clinical management and long-term follow up. J Neurosurg. 2002;97:299-306. Resumo

47. Melmed S, Casanueva FF, Hoffman AR, et al; Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273-288.Texto completo  Resumo

48. Raff H. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. J Clin Endocrinol Metab. 2009;94:3647-3655. Resumo

49. Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93:1553-1562.Texto completo  Resumo

50. Carroll T, Raff H, Findling JW. Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract. 2009;15:335-342. Resumo

51. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008 May;93(5):1526-40.Texto completo  Resumo

52. Jho DH, Biller BM, Agarwalla PK, et al. Pituitary apoplexy: large surgical series with grading system. World Neurosurg. 2014;82:781-790. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal